Skip to main content
. Author manuscript; available in PMC: 2022 Feb 10.
Published in final edited form as: Annu Rev Physiol. 2020 Nov 6;83:303–330. doi: 10.1146/annurev-physiol-031620-093815

Figure 1.

Figure 1

De novo ceramide synthesis pathway and known inhibitors shown to improve metabolic diseases. Schematic of the de novo ceramide biosynthesis pathway highlighting the key enzymes involved in ceramide biosynthesis and their respective inhibitors. Abbreviations: ASAH1, acid ceramidase; CERS, ceramide synthase; DES, dihydroceramide desaturase; KDSR, 3-ketodihydrosphingosine reductase; SPT, serine palmitoyltransferase; UGCG, UDP-glucose ceramide glucosyltransferase.